Debut’s Post

A new report from Synonym and Boston Consulting Group (BCG) has analyzed opportunities that would enable the sector to deliver bioproducts economically for mass adoption and in the process, create a rich asset class for real estate investors. Chief amongst these is the development of biofoundries: large standardized fermentation facilities that offer the economies of scale to break the cost inertia currently facing the sector. “Synthetic biology promises, to paraphrase the old slogan, better living – better stuff – through biology,” commented Joshua Lachter, Synonym Co-founder. “Synonym imagines a world where these products are ubiquitous in our daily lives, and this report examines how that potential can translate to the realities of industrial production." “Our findings offer fascinating clarity on the pathway to non-pharma commercial biomanufacturing in the short term,” says Jean-Francois Bobier, Partner, Deep Tech, at the Boston Consulting Group and a lead author of the report. “While our figures appear conservative compared to some analyses, the biofoundry model detailed by Synonym offers a clear route primed for robust investment immediately.” #foodtech #biomanufacturing #bioproducts

🌿 New York's Bio-Economy Funding: A $5 million investment aims to transform the hemp industry, promoting innovative products made from hemp and other biomaterials. Additionally, Gov. Hochul's commitment to agriculture extends to a $2.25 million initiative for pest management at @CornellUniversity, promoting a proactive approach to environmental, health, labor, and education challenges. This strategic funding positions New York as a leader in the bio-economy sector. while supporting sustainable practices and innovative product development. Let our experts help you develop in this rapidly evolving industry. Contact us via Link in Βio. Source: @Hemp Today #CanXChange #CanXChangeInsights #CannabisIndustry #NewYorkHemp #CannabisIndustryFunding #HempBioEconomy #CornellUniversity

Which areas of AgTech are in vogue at the moment and seeing growth? Having been in and around this space for 6-7 years now, the answer to this seems to change from one period to the next. Agri-meets-Biotech has always been a big part of the AgriTech scene, but seems to be gathering particular traction at the moment. Sustainable alternatives to agrochemicals, plant-based proteins... these are areas attracting big investment. We've recently been working with one of the UK's foremost Tech & Scientific Consultancies, with a prior history in the Medical / Pharma domain, on a couple of senior level roles geared towards building their presence in 'alternative' areas of biotech such as as food and agtech. Then there are AgTech ecosystems springing up in the US in the likes of St Louis and North Carolina, building around the bouyant Biotech scenes that already exist in those areas. This seems to be more than a fad... AgriFood-meets-Biotech looks like it will be a core part of the food system revolution over the coming years and decades! #agtech #foodtech #agrifood #biotech #biotechnology

The last, but not least, of our four squads is the Industrial #Biotech Squad. It consists of Michael Nettersheim, Jowita Sewerska, CFA, Jisk de Vries and Bernadette Lee. 💚 The ECBF is the first private #venturecapital fund dedicated exclusively to the (circular) bioeconomy. Of course, companies that have dedicated themselves to industrial biotechnology cannot be left out. The goal of this field is the development of biotechnological processes for the production of bio-based fine and platform chemicals for further processing in the chemical #industry or in sectors such as cosmetics, cleaning agents and plastics or adhesives. Our squad at the ECBF focuses on four different sectors: 🧪 Biobased Chemicals 🦠 Industrial Biotechnology 🏭 Biorefineries 👕 Textiles Using cutting-edge biotechnology and proprietary R&D tools and insights, our portfolio company Biosyntia, for example, is developing first-of-its-kind precision fermentation processes to replace fossil-based alternatives. Its vision is to develop a natural and environmentally friendly production process of essential nutritional active ingredients, reducing the use of petrochemically-based processes and driving a positive #environmental #impact. 💪🏼 We are excited to see what innovations still await us in the field of industrial biotechnology! 💡 eeden | SPINNOVA® | Resortecs | Lixea | Lignopure GmbH | PeelPioneers | CH-Bioforce Oy | EcoBean | PectCof B.V. | AmphiStar | CELLUGY® | Cambrium | BIOWEG | TripleW | Relement | Nature's Principles G2B BioSolutions Aps

Great to see European Circular Bioeconomy Fund (ECBF) is excited about new innovations in the field of industrial biotechnology / biobased chemicals. Relement is mentioned as specialty chemical start-up to keep an eye on. Thumbs up for all the companies mentioned below; let's all become succesfull. Together we combat climate change and change the future of chemical industry forever! #biobased #greenchemistry #startup #climatechange #co2reduction

Transitioning to biobased plastics 🌿 offers environmental benefits by reducing reliance on fossil fuels ⛽ and introducing biodegradable options 🌱. However, it faces challenges including higher costs 💸, performance matching issues 🔄, and potential competition for agricultural resources 🌽. Balancing these factors is essential for the successful adoption of biobased plastics. Inspired by this, we decided to include a panel discussion at our 4th Bioplastics Innovation Forum 🌍 on March 5th-6th in Munich, Germany 🇩🇪 - https://bit.ly/4atuXoU that will delve into this topic further 🗣️🔍. The panel discussion will be led by the moderator Dr. Anita Haider; Co-Founder & CEO at Emnandi Bioplastics 🎤, and the following panelists: Marco Versari; President at Biorepack 🏅, Anindya Mukherjee; Co-Founder & Executive Board Member; at GO!PHA 🌐, alberto castellanza; Managing Director at Novamont GmbH. We are looking forward to finding out more! #Bioplastics #Sustainability #InnovationForum #EnvironmentalBenefits #Biodegradable #MunichGermany #PanelDiscussion #BiobasedPlastics

The latest report from Synonym and the Boston Consulting Group (BCG), "Breaking the Cost Barrier in Biomanufacturing," is one of the most comprehensive analyses in the biomanufacturing industry and at Swan Neck Bio™ we're committed to removing any constraints to progress for the biosolutions urgently needed by a growing population so well laid out. It explores into the transformative potential of biomanufacturing, focusing on the opportunities and challenges that arise in meeting the future demand for biomanufacturing capacity. This report is an invaluable resource for start-ups and technical teams aiming to find sustainable solutions for their products. 🏆 Find below highlights and takeaways from Fábio Faria-Oliveira, our Chef Science Office: 🌱 Growing Demand for Biomanufactured Products: With nearly 200 nations transitioning away from fossil fuels, the demand for biomanufactured products is on the rise. Companies worldwide are committing to emissions reduction targets and net-zero goals, aligning with the broader sustainability movement. 💰 Market Potential: Scaling up industrial precision fermentation could lead to a staggering $200 billion market by 2040, surpassing the current market size. However, the primary constraint remains the capacity of biomanufacturing facilities. 💡 Cost Reduction Imperative: Achieving economically viable precision-fermentation biomanufacturing at a commercial scale is pivotal to bring production costs in line with existing methods. Synonym's report emphasizes the critical need to reduce production costs in biomanufacturing. 🏭 Role of Biofoundries: Large-scale standardized biomanufacturing facilities—Biofoundries— will hold a pivotal role of in optimizing processes and equipment to significantly lower production costs. This optimization is crucial for achieving price parity with current methods. 🌐 Challenges Ahead: From customer education and regulatory hurdles to competition with petrochemicals, addressing these challenges is key to unlocking the full potential of biomanufacturing. 📚 Key Takeaways: Efforts in cost reduction, regulatory alignment, and market development will be instrumental in shaping the future of biomanufacturing. Synonym's report serves as a valuable guide for start-up owners and technical teams navigating this dynamic landscape. 🔗 Read the full report here: https://lnkd.in/dqxvuiDA #Biomanufacturing #Sustainability #Innovation #foodinnovation #FutureTech #Startups #foodindustry #biotech #biotechnology #foodtech #foodtechnology

One of the value-adds from a 2BMonthly subscription is the exclusive interviews with leaders from across the industry, from c-level executives to associations and research institutes. Whether it's strategic insight, practical advice, or simply a nugget of wisdom, we feel these interviews are one reason why we have such long-term subscribers. 🚀 In 2023 alone, we ran 21 interviews including 👇 🧡Cutting-edge products - An interview with the CEO of Puna Bio, an Argentinian agtech company that has launched a soybean biostimulant using 'extremophile' bacteria. 🧡How to pitch your product - we asked Nutrien Ag Solutions to give us some dos and don'ts when pitching your product to a retailer ➡ "Setting price is complex... It requires knowing your competition very well and the practical value the product generates for the farmer.", Francisco Manzano. 🧡Nanotechnology - Hearing the market interest in nanotechnology, we ran an interview with the CEO of Aqua-yield, which uses silicon dioxide as porous nanoparticles. 🧡Career paths - We also like to learn about the career path of entrepreneurs in the biological space, such as the musician turned agtech CEO of CXC.C.”, François Lamoureux. 🧡Essential research -  We met the team in Brazil working on the country's first bioherbicide and got the lowdown on a new insect research facility at a Canadian university. 🧡State of the Industry – The was also the blockbuster State of the Industry that included viewpoints from an illustrious roll-call of industry participants (see below) Be sure to subscribe to 2BM to benefit from these valuable interviews in 2024! https://lnkd.in/ev_YV5C6 We're offering a time-limited 20% reduction on your first year's subscription 👉 contact [email protected] or [email protected] 2BMonthly The Global Biocontrol & Biostimulants E-Newsletter Contributors to State of the Industry included: Eduard Vallverdú Vidal, CEO, Sustainable Agro Solutions Frederic Beudot, Director & Global Portfolio Leader – Biologicals, Corteva Agriscience Salman Mir, Chief Operating Officer, Valent BioSciences Enric Bonet, CEO, Manvert Ashish Malik, President & CEO, Bee Vectoring Technologies Carlos Rodriguez-Villa Förster, Managing Director, AlgaEnergy Vittorio Veronelli, CEO, CBC Europe Daniel Zingg, Andermatt Madumbi Vladyslav Bolokhovskyi, CEO, BTU Center Ludwik Pokorny, Bioline Frederic Chagnon, Lallemand Plant Care Amy O'Shea, President & CEO, Certis Biologicals Benedicte Flambard, Vice President, Plant Health, FMC Pam Marrone, Co-founder & Executive Chair, Invasive Species Control Corporation James Thompson, Director of Business Development, Portfolio Management Biologicals and Non-Crop, AMVAC Peter Maes, Chief Strategy Officer, Koppert #newaginternational #biologicals #biocontrol #biofertilizers #biostimulants 

Make sure you check out this article from SynBioBeta! As we prepare to share more insights and advancements at the SynbioBeta 2024 Conference, join us in this journey towards a true bioeconomy 🚀 https://lnkd.in/dvjGazHf #SynBioBeta #PowBio #Biomanufacturing #MachineLearning #biomanufacturing #sustainability #innovation #synbio